Best practice and future challenges for vaccination against porcine circovirus type 2

Expert Review of Vaccines

Volumn 14, Issue 3, 2015, Pages 473-487

  Segalés, Joaquim ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

age of vaccination; immunity; maternally derived immunity; PCV2 subclinical infection; PCV2 systemic disease; pigs; porcine circovirus diseases; porcine circovirus type 2; sows; vaccine

Indexed keywords

PORCINE CIRCOVIRUS TYPE 2 VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ACTIVE IMMUNIZATION; CELLULAR IMMUNITY; CIRCOVIRIDAE INFECTION; CIRCOVIRUS; GENETIC VARIABILITY; HUMORAL IMMUNITY; MEDICAL PRACTICE; NONHUMAN; PIGLET; PRIORITY JOURNAL; REVIEW; SEROCONVERSION; VACCINATION; VACCINE FAILURE; VIRUS IMMUNITY; VIRUS LOAD; ANIMAL; ASYMPTOMATIC INFECTION; BODY WEIGHT; IMMUNOLOGY; PIG; PORCINE POSTWEANING MULTISYSTEMIC WASTING SYNDROME; PRACTICE GUIDELINE; PROCEDURES;

ANIMALS; ASYMPTOMATIC INFECTIONS; BODY WEIGHT; CIRCOVIRUS; PORCINE POSTWEANING MULTISYSTEMIC WASTING SYNDROME; PRACTICE GUIDELINES AS TOPIC; SWINE; VACCINATION; VIRAL VACCINES;

EID: 84923093604     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2015.983084     Document Type: Review

References (149)

1. Hamel AL, Lin LL, Nayar GP. Nucleotide sequence of porcine circovirus associated with postweaning multisystemic wasting syndrome in pigs. J Virol 1998;72:5262-7
2. Meehan BM, McNeilly F, Todd D, et al. Characterization of novel circovirus DNAs associated with wasting syndromes in pigs. J Gen Virol 1998;79(Pt 9):2171-9
3. Clark EG. Post-weaning multisystemic wasting syndrome. Proc West Can Assoc Swine Pr 1996;19-20
4. Harding JC. Postweaning multisystemic wasting syndrome: preliminary epidemiology and clinical findings. Proc West Can Assoc Swine Pr 1996;21
5. Allan G, Krakowka S, Ellis J, et al. Discovery and evolving history of two genetically related but phenotypically different viruses, porcine circoviruses 1 and 2. Virus Res 2012;164:4-9
6. Jacobsen B, Krueger L, Seeliger F, et al. Retrospective study on the occurrence of porcine circovirus 2 infection and associated entities in Northern Germany. Vet Microbiol 2009;138:27-33
7. Firth C, Charleston MA, Duffy S, et al. Insights into the evolutionary history of an emerging livestock pathogen: porcine circovirus 2. J Virol 2009;83:12813-21
8. Segalés J. Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis. Virus Res 2012; 164(1-2):10-19
9. Allan GM, McNeilly F, Ellis J, et al. PMWS: experimental model and co-infections. Vet Microbiol 2004;98:165-8
10. Allan GM, Kennedy S, McNeilly F, et al. Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. J Comp Pathol 1999;121:1-11
11. Balasch M, Segales J, Rosell C, et al. Experimental inoculation of conventional pigs with tissue homogenates from pigs with post-weaning multisystemic wasting syndrome. J Comp Pathol 1999;121:139-48
12. Ellis J, Krakowka S, Lairmore M, et al. Reproduction of lesions of postweaning multisystemic wasting syndrome in gnotobiotic piglets. J Vet Diagn Invest 1999;11:3-14
13. Evans AS, Street C, Haven N. Causation and disease: the Henle-Koch postulates revisited. Yale J Biol Med 1976;195:175-95
14. Tico G, Segales J, Martínez J. The blurred border between porcine circovirus type 2-systemic disease and porcine respiratory disease complex. Vet Microbiol 2013;163:242-7
15. Mankertz A, Domingo M, Folch JM, et al. Characterisation of PCV-2 isolates from Spain, Germany and France. Virus Res 2000;66:65-77
16. Segales J, Olvera A, Grau-Roma L, et al. PCV-2 genotype definition and nomenclature. Vet Rec 2008;162(26):867-8
17. Dupont K, Nielsen EO, Bækbo P, et al. Genomic analysis of PCV2 isolates from Danish archives and a current PMWS case-control study supports a shift in genotypes with time. Vet Microbiol 2008;128:56-64
18. Guo LJ, Lu YH, Wei YW, et al. Porcine circovirus type 2 (PCV2): genetic variation and newly emerging genotypes in China. Virol J 2010;7:273
19. Novosel D, Tuboly T, Csagola A, et al. Origin of porcine circovirus type 2 (PCV2) from swine affected by PCV2-associated diseases in Croatia. Vet Rec 2014;174(17): 431
20. Segales J, Kekarainen T, Cortey M. The natural history of porcine circovirus type 2: from an inoffensive virus to a devastating swine disease? Vet Microbiol 2013;165(1-2): 13-20
21. Rodŕiguez-Arrioja GM, Segales J, Calsamiglia M, et al. Dynamics of porcine circovirus type 2 infection in a herd of pigs with postweaning multisystemic wasting syndrome. Am J Vet Res 2002;63:354-7
22. Larochelle R, Magar R, D'Allaire S. Comparative serologic and virologic study of commercial swine herds with and without postweaning multisystemic wasting syndrome. Can J Vet Res 2003;67:114-20
23. Sibila M, Calsamiglia M, Segales J, et al. Use of a polymerase chain reaction assay and an ELISA to monitor porcine circovirus type 2 infection in pigs from farms with and without postweaning multisystemic wasting syndrome. Am J Vet Res 2004;65: 88-92
24. Carasova P, Celer V, Takacova K, et al. The levels of PCV2 specific antibodies and viremia in pigs. Res Vet Sci 2007;83:274-8
25. Grau-Roma L, Hjulsager CK, Sibila M, et al. Infection, excretion and seroconversion dynamics of porcine circovirus type 2 (PCV2) in pigs from post-weaning multisystemic wasting syndrome (PMWS) affected farms in Spain and Denmark. Vet Microbiol 2009;135:272-82
26. Meerts P, Misinzo G, Lefebvre D, et al. Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease. BMC Vet Res 2006;2:6
27. Bolin SR, Stoffregen WC, Nayar GP, et al. Postweaning multisystemic wasting syndrome induced after experimental inoculation of cesarean-derived, colostrum-deprived piglets with type 2 porcine circovirus. J Vet Diagn Invest 2001;13:185-94
28. Ladekjaer-Mikkelsen AS, Nielsen J, Stadejek T, et al. Reproduction of postweaning multisystemic wasting syndrome (PMWS) in immunostimulated and non-immunostimulated 3-week-old piglets experimentally infected with porcine circovirus type 2 (PCV2). Vet Microbiol 2002;89(2-3):97-114
29. Rovira A, Balasch M, Segalés J, et al. Experimental inoculation of conventional pigs with porcine reproductive and respiratory syndrome virus and porcine circovirus 2. J Virol 2002;76:3232-9
30. Okuda Y, Ono M, Yazawa S, et al. Experimental reproduction of postweaning multisystemic wasting syndrome in cesarean-derived, colostrum-deprived piglets inoculated with porcine circovirus type 2 (PCV2): investigation of quantitative PCV2 distribution and antibody responses. J Vet Diagn Invest 2003;15:107-14
31. McIntosh Ka, Harding JCS, Ellis Ja, et al. Detection of Porcine circovirus type 2 viremia and seroconversion in naturally infected pigs in a farrow-to-finish barn. Can J Vet Res 2006;70(1):58-61
32. Fort M, Olvera A, Sibila M, et al. Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs. Vet Microbiol 2007;125:244-55
33. Pogranichnyy RM, Yoon KJ, Harms PA, et al. Characterization of immune response of young pigs to porcine circovirus type 2 infection. Viral Immunol 2000;13: 143-53
34. Darwich L, Segalés J, Domingo M, et al. Changes in CD4+, CD8+, CD4+ CD8+, and immunoglobulin M-positive peripheral blood mononuclear cells of postweaning multisystemic wasting syndrome-affected pigs and age-matched uninfected wasted and healthy pigs correlate with lesions and porcine circovirus. Clin Diagn Lab Immunol 2002;9(2):236-42
35. Nielsen J, Vincent IE, Bøtner A, et al. Association of lymphopenia with porcine circovirus type 2 induced postweaning multisystemic wasting syndrome (PMWS). Vet Immunol Immunopathol 2003;92: 97-111
36. Krakowka S, Ellis JA, McNeilly F, et al. Immunologic features of porcine circovirus type 2 infection. Viral Immunol 2002; 15(4):567-82
37. Kawashima K, Tsunemitsu H, Horino R, et al. Effects of dexamethasone on the pathogenesis of porcine circovirus type 2 infection in piglets. J Comp Pathol 2003;129:294-302
38. Meerts P, Van Gucht S, Cox E, et al. Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication. Viral Immunol 2005;18:333-41
39. Fort M, Fernandes LT, Nofrarias M, et al. Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets. Vet Immunol Immunopathol 2009;129:101-7
40. Fort M, Sibila M, Pérez-Martín E, et al. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model. Vaccine 2009;27:4031-7
41. Fort M, Sibila M, Nofraŕias M, et al. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine. Vet Immunol Immunopathol 2012;150:128-32
42. Steiner E, Balmelli C, Gerber H, et al. Cellular adaptive immune response against porcine circovirus type 2 in subclinically infected pigs. BMC Vet Res 2009;5:45
43. Martelli P, Ferrari L, Morganti M, et al. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions. Vet Microbiol 2011;149(3-4): 339-51
44. Ferrari L, Borghetti P, De Angelis E, et al. Memory T cell proliferative responses and IFN-g productivity sustain long-lasting efficacy of a Cap-based PCV2 vaccine upon PCV2 natural infection and associated disease. Vet Res 2014;45:44
45. Beach NM, Meng XJ. Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2). Virus Res 2012; 164(1-2):33-42
46. Girard MP, Plotkin SA. HIV vaccine development at the turn of the 21st century. Curr Opin HIV AIDS 2012;7:4-9
47. Ganges L, Borrego B, Fernandez-Pacheco P, et al. DNA immunization of pigs with foot-and-mouth disease virus minigenes: from partial protection to disease exacerbation. Virus Res 2011;157:121-5
48. Pogranichniy RM, Yoon K-J, Yaeger MJ, et al. Efficacy of experimental inactivated PCV2 vaccines for preventing PMWS in CDCD pigs. Proc Annu Meet Am Assoc Swine Vet 2004;35:443-4
49. Yang K, Li W, Niu H, et al. Efficacy of single dose of an inactivated porcine circovirus type 2 (PCV2) whole-virus vaccine with oil adjuvant in piglets. Acta Vet Scand 2012;54:67
50. Reynaud G, Beseme S, Brun A, et al. Safety of a high dose administration of an inactivated adjuvanted PCV2 vaccine in conventional gilts. In: Proceedings of the 18th International Pig Veterinary Society; 2004. P87
51. Reynaud G, Brun A, Charreyre C, et al. Safety of repeated overdose on an inactivated adjuvanted PCV2 vaccine in conventional pregnant gilts and sows. In: Proceedings of the 18th International Pig Veterinary Society Congress 2004. P88
52. Blanchard P, Mahe D, Cariolet R, et al. Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine 2003;21:4565-75
53. Perez-Martin E, Grau-Roma L, Argilaguet JM, et al. Development of two Trichoplusia ni larvae-derived ELISAs for the detection of antibodies against replicase and capsid proteins of porcine circovirus type 2 in domestic pigs. J Virol Methods 2008; 154(1-2): 167-74
54. Ju C, Fan H, Tan Y, et al. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2. Vet Microbiol 2005;109:179-90
55. Wang X, Jiang P, Li Y, et al. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2. Vet Microbiol 2007;121:215-24
56. Fan H, Pan Y, Fang L, et al. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice. J Virol Methods 2008;150:21-6
57. Wang K, Huang L, Kong J, et al. Expression of the capsid protein of porcine circovirus type 2 in Lactococcus lactis for oral vaccination. J Virol Methods 2008;150: 1-6
58. Aravindaram K, Kuo TY, Lan CW, et al. Protective immunity against porcine circovirus 2 in mice induced by a gene-based combination vaccination. J Gene Med 2009;11:288-301
59. Bucarey SA, Noriega J, Reyes P, et al. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts. Vaccine 2009;27:5781-90
60. Pérez-Martín E, Gómez-Sebastián S, Argilaguet JM, et al. Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae. Vaccine 2010;28: 2340-9
61. Lin HX, Ma Z, Fan HJ, Lu CP. Construction and immunogenicity of recombinant swinepox virus expressing capsid protein of PCV2. Vaccine 2012;30: 6307-13
62. Gellért A, Salánki K, Tombácz K, et al. A cucumber mosaic virus based expression system for the production of porcine circovirus specific vaccines. PLoS One 2012; 7(12):e52688
63. Cságola A, Lorincz M, Tombácz K, et al. Genetic diversity of pigeon circovirus in Hungary. Virus Genes 2012;44:75-9
64. Tombácz K, Gellért A, Salánki K, et al. Oral immunogenicity of a plant virus vector based porcine circovirus antigen. Acta Vet Hung 2013;61(4):547-52
65. Chang HT, He XY, Chen L, et al. Enhancing mucosal immunity in mice induced by recombinant adenovirus expressing major epitopes of porcine circovirus-2 capsid protein formulated with CpG ODN. J Vet Sci 2014;15(3):399-407
66. Chi J-N, Wu C-Y, Chien M-S, et al. The preparation of porcine circovirus type 2 (PCV2) virus-like particles using a recombinant pseudorabies virus and its application to vaccine development. J Biotechnol 2014;181:12-19
67. Silva JG, Coimbra EC, Jesus ALS, et al. Secretory expression of porcine circovirus type 2 capsid protein in Pichia pastoris. J Virol Methods 2014;207C:226-31
68. Shen H-G, Zhou J-Y, Huang Z-Y, et al. Protective immunity against porcine circovirus 2 by vaccination with ORF2-based DNA and subunit vaccines in mice. J Gen Virol 2008;89:1857-65
69. Kamstrup S, Barfoed AM, Frimann TH, et al. Immunisation against PCV2 structural protein by DNA vaccination of mice. Vaccine 2004;22:1358-61
70. An DJ, Song DS, Park BK. Systemic cytokine profiles of mice vaccinated with naked DNAs encoding six open reading frame antigens of porcine circovirus type 2 (PCV2). Res Vet Sci 2008;85:503-9
71. Fu F, Li X, Lang Y, et al. Co-expression of ubiquitin gene and capsid protein gene enhances the potency of DNA immunization of PCV2 in mice. Virol J 2011;8:264
72. Sylla S, Cong Y-L, Sun Y-X, et al. Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice. Microbiol Immunol 2014;58(7): 398-408
73. Fenaux M, Opriessnig T, Halbur PG, et al. Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs. J Virol 2003;77:11232-43
74. Fenaux M, Opriessnig T, Halbur PG, et al. A Chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. J Virol 2004; 78(12):6297-303
75. Beach NM, Ramamoorthy S, Opriessnig T, et al. Novel chimeric porcine circovirus (PCV) with the capsid gene of the emerging PCV2b subtype cloned in the genomic backbone of the non-pathogenic PCV1 is attenuated in vivo and induces protective and cross-protective immunity against PCV2b and PCV2a subtype. Vaccine 2010; 29(2):221-32
76. Hemann M, Beach NM, Meng X-J, et al. A live-attenuated and an inactivated chimeric porcine circovirus (PCV)1-2 vaccine are both effective at inducing a humoral immune response and reducing PCV2 viremia and intrauterine infection in female swine of breeding age. Can J Vet Res 2014;78(1):8-16
77. Xujie L, Xiaobo W, Yi S, et al. A candidate inactivated chimeric vaccine PCV1-2 constructed based on PCV1 and PCV2 isolates originating in China and its evaluation in conventional pigs in regard to protective efficacy against PCV2 infection. Microbiol Immunol 2011;55(4):254-66
78. Chae C. Porcine circovirus type 2 and its associated diseases in Korea. Virus Res 2012;164:107-13
79. Zhai S-L, Chen S-N, Xu Z-H, et al. Porcine circovirus type 2 in China: an update on and insights to its prevalence and control. Virol J 2014;11:88
80. Pejsak Z, Podgórska K, Truszczyński M, et al. Efficacy of different protocols of vaccination against porcine circovirus type 2 (PCV2) in a farm affected by postweaning multisystemic wasting syndrome (PMWS). Comp Immunol Microbiol Infect Dis 2010; 33(6):e1-5
81. Opriessnig T, Patterson AR, Madson DM, et al. Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination. Vet Microbiol 2010;142: 177-83
82. O'Neill KC, Hemann M, Gimenez-Lirola LG, et al. Vaccination of sows reduces the prevalence of PCV-2 viraemia in their piglets under field conditions. Vet Rec 2012;171:425-83. Kurmann J, Sydler T, Brugnera E, et al.
83. Vaccination of dams increases antibody titer and improves growth parameters in finisher pigs subclinically infected with porcine circovirus type 2. Clin Vaccine Immunol 2011;18(10):1644-9
84. Gerber PF, Garrocho FM, Lana AM, et al. Fetal infections and antibody profiles in pigs naturally infected with porcine circovirus type 2 (PCV2). Can J Vet Res 2012;76: 38-44
85. Gerber PF, Garrocho FM, Lana AMQ, et al. Serum antibodies and shedding of infectious porcine circovirus 2 into colostrum and milk of vaccinated and unvaccinated naturally infected sows. Vet J 2011;188:240-2
86. Fraile L, Sibila M, Nofraŕias M, et al. Effect of sow and piglet porcine circovirus type 2 (PCV2) vaccination on piglet mortality, viraemia, antibody titre and production parameters. Vet Microbiol 2012;161:229-34
87. Pejsak Z, Markowska-Daniel I, Pomorska-Mól M, et al. Ear necrosis reduction in pigs after vaccination against PCV2. Res Vet Sci 2011;91:125-8
88. Pejsak Z, Kusior G, Pomorska-Mól M, et al. Influence of long-term vaccination of a breeding herd of pigs against PCV2 on reproductive parameters. Pol J Vet Sci 2012;15(1):37-42
89. Villa T. PCV2 and reproductive performance: facts and figures for the disbelievers. In: merial Symposium. 18th IPVS; Durban, South Africa; 2008
90. Thacker BJ, Wilson W, Francisco C, et al. Circumvent PCV vaccine: performance evaluation and serological studies update. In: Proceedings of the American Association of Swine Veterinarians; 2008. p. 153-6
91. Madson DM, Patterson AR, Ramamoorthy S, et al. Effect of porcine circovirus type 2 (PCV2) vaccination of the dam on PCV2 replication in utero. Clin Vaccine Immunol 2009;16:830-4
92. Larochelle R, Bielanski A, Müller P, et al. PCR detection and evidence of shedding of porcine circovirus type 2 in boar semen. J Clin Microbiol 2000;38:4629-32
93. Seo HW, Han K, Kim D, et al. Effects of an inactivated porcine circovirus type 2 (PCV2) vaccine on PCV2 virus shedding in semen from experimentally infected boars. Clin Vaccine Immunol 2011;18:1091-6
94. Madson DM, Ramamoorthy S, Kuster C, et al. Infectivity of porcine circovirus type 2 DNA in semen from experimentally-infected boars. Vet Res 2009; 40(1):10
95. Seo HW, Han K, Oh Y, et al. Comparison of three commercial one-dose porcine circovirus type 2 (PCV2) vaccines on PCV2 shedding in semen from experimentally infected boars. Vet Microbiol 2013;164:145-9
96. Opriessnig T, Madson DM, Schalk S, et al. Porcine circovirus type 2 (PCV2) vaccination is effective in reducing disease and PCV2 shedding in semen of boars concurrently infected with PCV2 and Mycoplasma hyopneumoniae. Theriogenology 2011;76:351-60
97. Caspari K, Henning H, Schreiber F, et al. Impact of porcine circovirus type 2 (PCV2) vaccination on boar semen quality and quantity using two different vaccines. Theriogenology 2014;82(4):574-9
98. Fort M, Sibila M, Allepuz A, et al. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine 2008;26: 1063-71
99. Opriessnig T, Patterson AR, Elsener J, et al. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2. Clin Vaccine Immunol 2008;15:397-401
100. Opriessnig T, Patterson AR, Madson DM, et al. Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination. Vaccine 2009;27:1002-7
101. Park C, Oh Y, Seo HW, et al. Comparative effects of vaccination against porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) in a PCV2-PRRSV challenge model. Clin Vaccine Immunol 2013;20: 369-76
102. Park C, Won Seo H, Han K, et al. Comparison of four commercial one-dose porcine circovirus type 2 (PCV2) vaccines administered to pigs challenged with PCV2 and porcine reproductive and respiratory syndrome virus at 17 weeks postvaccination to control porcine respiratory disease complex u. Clin Vaccine Immunol 2014;21(7):1021.
103. Han K, Seo HW, Oh Y, et al. Efficacy of a piglet-specific commercial inactivated vaccine against Porcine circovirus type 2 in clinical field trials. Can J Vet Res 2013;77: 237-40
104. Takada-Iwao A, Seki M, Nakanishi M, et al. Porcine circovirus type 2 (PCV2) vaccination reduces PCV2 in a PCV2 and Salmonella enterica serovar Choleraesuis coinfection model. Vet Microbiol 2013; 162(1):219-23
105. Seo HW, Han K, Park C, et al. Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines. Vet J 2014;200:65-70
106. Seo HW, Park C, Han K, et al. Effect of porcine circovirus type 2 (PCV2) vaccination on PCV2-viremic piglets after experimental PCV2 challenge. Vet Res 2014;45:13
107. Cline G, Wilt V, Diaz E, et al. Efficacy of immunising pigs against porcine circovirus type 2 at three or six weeks of age. Vet Rec 2008; 163(25):737-40
108. Fachinger V, Bischoff R, Jedidia SB, et al. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex. Vaccine 2008;26:1488-99
109. Horlen KP, Dritz SS, Nietfeld JC, et al. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2. J Am Vet Med Assoc 2008;232:906-12
110. Kixmoller M, Ritzmann M, Eddicks M, et al. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2. Vaccine 2008;26: 3443-51
111. Desrosiers R, Clark E, Tremblay D, et al. Use of a one-dose subunit vaccine to prevent losses associated with porcine circovirus type 2. J Swine Heal Prod 2009;17:148-54
112. Segales J, Urniza A, Alegre A, et al. A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms. Vaccine 2009;27:7313-21
113. Martelli P, Ardigo P, Ferrari L, et al. Concurrent vaccinations against PCV2 and PRRSV: study on the specific immunity and clinical protection in naturally infected pigs. Vet Microbiol 2013;162:558-71
114. Lyoo K, Joo H, Caldwell B, et al. Comparative efficacy of three commercial PCV2 vaccines in conventionally reared pigs. Vet J 2011;189:58-62
115. Kristensen CS, Baadsgaard NP, Toft N. A meta-analysis comparing the effect of PCV2 vaccines on average daily weight gain and mortality rate in pigs from weaning to slaughter. Prev Vet Med 2011;98(4):250-8
116. Young MG, Cunningham GL, Sanford SE. Circovirus vaccination in pigs with subclinical porcine circovirus type 2 infection complicated by ileitis. J Swine Heal Prod 2011;19:6
117. Fraile L, Grau-Roma L, Sarasola P, et al. Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity. Vaccine 2012;30:1986-92
118. Alarcon P, Rushton J, Wieland B. Cost of post-weaning multi-systemic wasting syndrome and porcine circovirus type-2 subclinical infection in England-an economic disease model. Prev Vet Med 2013;110(2):88-102
119. Gagnon CA, Music N, Fontaine G, et al. Emergence of a new type of porcine circovirus in swine (PCV): a type 1 and type 2 PCV recombinant. Vet Microbiol 2010;144:18-23
120. Seo HW, Oh Y, Han K, et al. Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge. BMC Vet Res 2012;8:194
121. Oh Y, Seo HW, Park C, et al. Comparison of sow and/or piglet vaccination of 3 commercial porcine circovirus type 2 (PCV2) single-dose vaccines on pigs under experimental PCV2 challenge. Vet Microbiol 2014;172(3-4):371-80
122. Seo HW, Lee J, Han K, et al. Comparative analyses of humoral and cell-mediated immune responses upon vaccination with different commercially available single-dose porcine circovirus type 2 vaccines. Res Vet Sci 2014;97(1):38-42
123. Borghetti P, Morganti M, Saleri R, et al. Innate pro-inflammatory and adaptive immune cytokines in PBMC of vaccinated and unvaccinated pigs naturally exposed to porcine circovirus type 2 (PCV2) infection vary with the occurrence of the disease and the viral burden. Vet Microbiol 2013; 163(1-2):42-53
124. Sibila M, Fraile L, Tico G, et al. Humoral response and colostral antibody transfer following "one-dose" pre-mating vaccination of sows against porcine circovirus type-2. Vet J 2013;197:881-3
125. Goubier A, Chapat L, Toma S, et al. Transfer of maternal immunity from sows vaccinated against PCV2 with Circovac to their piglets. In: Proceedings of the 18th International Pig Veterinary Society; 2004. O16
126. Oh Y, Seo HW, Han K, et al. Protective effect of the maternally derived porcine circovirus type 2 (PCV2)-specific cellular immune response in piglets by dam vaccination against PCV2 challenge. J Gen Virol 2012;93:1556-62
127. Haake M, Palzer A, Rist B, et al. Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies. Vet Microbiol 2014;168:272-80
128. Armstrong D, Bishop SC. Does genetics or litter effect influence mortality in PMWS. In: Proceedings of the 18th International Pig Veterinary Society 2004. P809
129. Burch D. Ten years of PCV2 in the UK. Pig Prog 2009;25:6
130. Cino-Ozuna AG, Henry S, Hesse R, et al. Characterization of a New Disease Syndrome Associated with Porcine Circovirus Type 2 in Previously Vaccinated Herds. J Clin Microbiol 2011;49:2012-16
131. Takahagi Y, Toki S, Nishiyama Y, et al. Differential effects of porcine circovirus type 2 (PCV2) vaccination on PCV2 genotypes at Japanese pig farms. J Vet Med Sci 2010;72(1):35-41
132. Olvera A, Cortey M, Segalés J. Molecular evolution of porcine circovirus type 2 genomes: phylogeny and clonality. Virology 2007;357:175-85
133. Opriessnig T, O'Neill K, Gerber PF, et al. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection. Vaccine 2013;31(3):487-94
134. Opriessnig T, Xiao CT, Gerber PF, et al. Emergence of a novel mutant PCV2b variant associated with clinical PCVAD in two vaccinated pig farms in the U.S. concurrently infected with PPV2. Vet Microbiol 2013;163:177-83
135. Xiao C-T, Halbur PG, Opriessnig T. Complete genome sequence of a novel porcine circovirus type 2b variant present in cases of vaccine failures in the United States. J Virol 2012;86:12469
136. Guo L, Fu Y, Wang Y, et al. A porcine circovirus type 2 (PCV2) mutant with 234 amino acids in Capsid protein showed more virulence in vivo, compared with classical PCV2a/b strain. PLoS One 2012; 7(7):e41463
137. Salgado RL, Vidigal PMP, de Souza LFL, et al. Identification of an emergent porcine circovirus-2 in vaccinated pigs from a Brazilian farm during a postweaning multisystemic wasting syndrome outbreak. Genome Announc 2014;2(2):e00163-14
138. Seo HW, Park C, Kang I, et al. Genetic and antigenic characterization of a newly emerging porcine circovirus type 2b mutant first isolated in cases of vaccine failure in Korea. Arch Virol 2014;159(11):3107-11
139. Opriessnig T, Gerber PF, Xiao CT, et al. Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2. Vaccine 2014;32:4342-8
140. Opriessnig T, Xiao C-T, Gerber PF, et al. The mutant U.S. strain of porcine circovirus type 2 (mPCV2) exhibits similar virulence to the classical PCV2a and PCV2b strains in caesarian-derived colostrum-deprived pigs. J Gen Virol 2014;95(Pt 11):2495-503
141. Kekarainen T, Gonzalez A, Llorens A, et al. Genetic variability of porcine circovirus 2 in vaccinating and non-vaccinating commercial farms. J Gen Virol 2014;95(Pt 8):1734-42
142. Segales J, Domingo M, Chianini F, et al. Immunosuppression in postweaning multisystemic wasting syndrome affected pigs. Vet Microbiol 2004;98(2):151-8
143. Grau-Roma L, Fraile L, Segalés J. Recent advances in the epidemiology, diagnosis and control of diseases caused by porcine circovirus type 2. Vet J 2011;187(1):23-32
144. Vigre H, Dohoo IR, Stryhn H, et al. Use of register data to assess the association between use of antimicrobials and outbreak of Postweaning Multisystemic Wasting Syndrome (PMWS) in Danish pig herds. Prev Vet Med 2010;93:98-109
145. Glass F. PCV2 vaccination changing the pig industry. Part 3. Reduced antibiotic usage and improved performance go together. Pig Prog 2010;26(2):28-30
146. Kurtz S, Grau-Roma L, Cortey M, et al. Pigs naturally exposed to porcine circovirus type 2 (PCV2) generate antibody responses capable to neutralise PCV2 isolates of different genotypes and geographic origins. Vet Res 2014;45:29
147. Opriessnig T, Yu S, Thacker EL, et al. Derivation of porcine circovirus type 2-negative pigs from positive breeding herds. J Swine Health Prod 2004;12(4): 186-91
148. Patterson AR, Madson DM, Schalk S, et al. Establishment and maintenance of a porcine circovirus type 2 (PCV2)-free breeding herd on a site that experienced a natural outbreak of PCV2-associated reproductive disease. J Swine Heal Prod 2011;19(3):165-74
149. Feng H, Blanco G, Segalés J, et al. Can Porcine circovirus type 2 (PCV2) infection be eradicated by mass vaccination? Vet Microbiol 2014;172:92-9